Emergence of KRAS-mutation in liver metastases after an anti-EGFR treatment in patient with colorectal cancer: are we aware of the therapeutic impact of intratumor heterogeneity? / Baretti, M; Personeni, N; Destro, A; Santoro, A; Rimassa, L. - In: CANCER BIOLOGY & THERAPY. - ISSN 1538-4047. - 19:8(2018), pp. 659-663. [10.1080/15384047.2018.1450117]
Emergence of KRAS-mutation in liver metastases after an anti-EGFR treatment in patient with colorectal cancer: are we aware of the therapeutic impact of intratumor heterogeneity?
Personeni N;Santoro A;
2018-01-01
File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
